Balance Sheet Carl Zeiss Meditec AG

Equities

AFX

DE0005313704

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 16:35:04 10/04/2026 BST			5-day change	1st Jan Change
25.94 ^EUR	+1.65%		+4.43%	-35.15%

04-07	Carl Zeiss Meditec rebounds as Goldman Sachs turns cautiously optimistic	DP
04-07	CARL ZEISS MEDITEC AG : Gets a Neutral rating from Goldman Sachs	ZD

10c039335101686a0e6a6dff58f921.HeYU_I2dLHJD-KOa280oatr5MUDJpCxhgHerNbmUbW4.dZ55qrTzFAIMgefXt6d3XrO2ZRqL8lQ50DPaR-vxNQB_sneo4ehaO3SRzA

Published financial data: CARL ZEISS MEDITEC AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	1.65B	1.9B	2.09B	2.07B	2.23B
Total Revenues	1.65B	1.9B	2.09B	2.07B	2.23B
Cost of Goods Sold, Total	680M	775M	884M	977M	1.05B
Gross Profit	967M	1.13B	1.21B	1.09B	1.18B
Selling General & Admin Expenses, Total	365M	437M	503M	558M	627M
R&D Expenses	232M	291M	349M	343M	326M
Other Operating Expenses	-	-	-	-	-917K
Other Operating Expenses, Total	597M	729M	852M	901M	952M
Operating Income	370M	399M	354M	187M	223M
Interest Expense, Total	-8.58M	-9.1M	-15.25M	-29.42M	-26.6M
Interest And Investment Income	1.56M	13.25M	28.11M	22.4M	6.57M
Net Interest Expenses	-7.02M	4.15M	12.86M	-7.03M	-20.03M
Income (Loss) On Equity Invest.	-	-	-893K	-3.02M	30K
Currency Exchange Gains (Loss)	-25.1M	-48.63M	38.2M	11.58M	-10.46M
Other Non Operating Income (Expenses)	88K	-2.05M	-1.85M	205K	-3.62M
EBT, Excl. Unusual Items	338M	352M	402M	189M	189M
Merger & Related Restructuring Charges	-	-1.2M	-300K	-10.2M	-
Gain (Loss) On Sale Of Investments	95K	87K	-	-	-
Gain (Loss) On Sale Of Assets	2.45M	-	-	-	-
Legal Settlements	-	-	-	18.12M	-
Other Unusual Items	-1.84M	52.25M	10.88M	43.8M	4.68M
EBT, Incl. Unusual Items	339M	403M	413M	241M	194M
Income Tax Expense	102M	108M	121M	60.71M	51.55M
Earnings From Continuing Operations	238M	296M	292M	180M	142M
Net Income to Company	238M	296M	292M	180M	142M
Minority Interest	-1.24M	-2M	-1.61M	-1.43M	-1.14M
Net Income - (IS)	236M	294M	290M	179M	141M
Net Income to Common Incl Extra Items	236M	294M	290M	179M	141M
Net Income to Common Excl. Extra Items	236M	294M	290M	179M	141M
Per Share Items
Net EPS - Basic	2.64	3.29	3.25	2.01	1.61
Basic EPS - Continuing Operations	2.64	3.29	3.25	2.01	1.61
Basic Weighted Average Shares Outstanding	89.44M	89.44M	89.44M	88.85M	87.54M
Net EPS - Diluted	2.64	3.29	3.25	2.01	1.61
Diluted EPS - Continuing Operations	2.64	3.29	3.25	2.01	1.61
Diluted Weighted Average Shares Outstanding	89.44M	89.44M	89.44M	88.85M	87.54M
Normalized Basic EPS	2.35	2.44	2.79	1.31	1.34
Normalized Diluted EPS	2.35	2.44	2.79	1.31	1.34
Dividend Per Share	0.9	1.1	1.1	0.6	0.55
Payout Ratio	18.93	27.39	33.88	54.95	37.19
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	389M	419M	375M	225M	274M
EBITA	372M	400M	355M	200M	247M
EBIT	370M	399M	354M	187M	223M
EBITDAR	390M	421M	377M	228M	276M
Effective Tax Rate - (Ratio)	29.95	26.66	29.22	25.21	26.59
Current Domestic Taxes	95.79M	107M	-	-	-
Current Foreign Taxes	5.51M	7.64M	-	-	-
Total Current Taxes	101M	115M	108M	81.61M	64.4M
Deferred Domestic Taxes	-1.9M	791K	-	-	-
Deferred Foreign Taxes	2.13M	-8.12M	-	-	-
Total Deferred Taxes	223K	-7.33M	12.4M	-20.89M	-12.85M
Normalized Net Income	210M	218M	250M	117M	117M
Interest on Long-Term Debt	-	-	2.54M	4.11M	4.09M
Non-Cash Pension Expense	787K	494K	-936K	-877K	24K
Supplemental Operating Expense Items
Selling and Marketing Expenses	303M	360M	420M	458M	495M
General and Administrative Expenses	60.75M	76.68M	83.48M	101M	131M
Research And Development Expense From Footnotes	252M	317M	376M	409M	374M
Net Rental Expense, Total	1.43M	1.63M	2.11M	3.08M	2.65M
Imputed Operating Lease Interest Expense	1.04M	954K	1.81M	2.04M	1.04M
Imputed Operating Lease Depreciation	397K	678K	294K	1.04M	1.61M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.44M	7.73M	10.6M	20.28M	27.27M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	7.44M	7.73M	10.6M	20.28M	27.27M
Accounts Receivable, Total	324M	416M	421M	438M	521M
Other Receivables	970M	949M	876M	145M	171M
Notes Receivable	-	-	-	-	-
Total Receivables	1.29B	1.37B	1.3B	583M	692M
Inventory	286M	383M	520M	537M	497M
Prepaid Expenses	8.56M	12.45M	-	-	-
Other Current Assets, Total	7.95M	23.66M	83.75M	72.71M	64.14M
Total Current Assets	1.6B	1.79B	1.91B	1.21B	1.28B
Gross Property Plant And Equipment	358M	424M	483M	525M	584M
Accumulated Depreciation	-180M	-223M	-232M	-262M	-298M
Net Property Plant And Equipment	177M	201M	251M	264M	286M
Long-term Investments	6.71M	10.83M	21.46M	20.38M	28.93M
Goodwill	329M	430M	416M	983M	970M
Other Intangibles, Total	16.58M	15.6M	13.31M	304M	280M
Accounts Receivable Long-Term	9.19M	8.47M	7.02M	8.56M	9.39M
Loans Receivable Long-Term	-	152K	6.12M	6.66M	10.17M
Deferred Tax Assets Long-Term	84.96M	71.75M	63.7M	86.32M	82.26M
Deferred Charges Long-Term	137M	225M	246M	402M	383M
Other Long-Term Assets, Total	31.28M	68.39M	96.96M	106M	73.87M
Total Assets	2.4B	2.82B	3.03B	3.39B	3.4B
Liabilities
Accounts Payable, Total	145M	189M	240M	184M	194M
Accrued Expenses, Total	93.07M	102M	107M	124M	132M
Current Portion of Long-Term Debt	-	-	-	2.48M	2.48M
Current Portion of Leases	19.34M	21.59M	21.82M	24.59M	24.14M
Current Income Taxes Payable	21.56M	16.44M	18.88M	9.84M	10.17M
Unearned Revenue Current, Total	31.54M	39.91M	-	-	-
Other Current Liabilities	137M	170M	175M	225M	181M
Total Current Liabilities	448M	539M	562M	569M	544M
Long-Term Debt	-	-	-	400M	400M
Long-Term Leases	102M	106M	134M	127M	108M
Pension & Other Post Retirement Benefits	56.9M	11.61M	7.66M	14.9M	8.7M
Deferred Tax Liability Non Current	15.44M	22.38M	35.04M	138M	132M
Other Non Current Liabilities	96.2M	113M	122M	87.75M	82.62M
Total Liabilities	719M	793M	860M	1.34B	1.28B
Common Stock, Total	89.44M	89.44M	89.44M	89.44M	89.44M
Additional Paid In Capital	620M	620M	620M	620M	620M
Retained Earnings	1B	1.21B	1.41B	1.49B	1.58B
Treasury Stock	-	-	-	-150M	-150M
Comprehensive Income and Other	-50.73M	91.63M	43.97M	-4.23M	-18.11M
Total Common Equity	1.66B	2.02B	2.16B	2.04B	2.12B
Minority Interest	18.06M	14.99M	13.45M	14.78M	11.19M
Total Equity	1.68B	2.03B	2.17B	2.06B	2.13B
Total Liabilities And Equity	2.4B	2.82B	3.03B	3.39B	3.4B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	89.44M	89.44M	89.44M	87.54M	87.54M
ECS Total Common Shares Outstanding	89.44M	89.44M	89.44M	87.54M	87.54M
Book Value / Share	18.55	22.53	24.14	23.32	24.18
Tangible Book Value	1.31B	1.57B	1.73B	755M	867M
Tangible Book Value Per Share	14.69	17.55	19.35	8.62	9.9
Total Debt	121M	128M	156M	554M	535M
Net Debt	114M	120M	145M	534M	508M
Debt Equivalent of Unfunded Proj. Benefit Obligation	48.52M	-19.27M	-15.61M	7.73M	534K
Debt Equivalent Oper. Leases	11.47M	13.06M	16.87M	24.66M	21.21M
Minority Interest, Total (Incl. Fin. Div)	18.06M	14.99M	13.45M	14.78M	11.19M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	128M	180M	229M	271M	266M
Inventories - Work In Process, Total	37.38M	53.83M	57.62M	47.19M	51.4M
Inventories - Finished Goods, Total	166M	198M	282M	267M	241M
Inventories - Others	-	-	613K	393K	227K
Land - (BS)	161M	182M	208M	223M	264M
Machinery, Total	197M	242M	275M	303M	319M
Full Time Employees	3.53K	4.22K	4.82K	5.73K	5.78K
Accumulated Allowance for Doubtful Accounts (Supple)	11.22M	8.83M	8.83M	-	-
Order Backlog	274M	663M	409M	283M	380M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	236M	294M	290M	179M	141M
Depreciation & Amortization - CF	35.88M	39.46M	43.9M	51.91M	52.44M
Amortization of Goodwill and Intangible Assets - (CF)	1.43M	847K	1.22M	12.12M	23.45M
Depreciation & Amortization, Total	37.31M	40.31M	45.12M	64.03M	75.89M
Amortization of Deferred Charges, Total - (CF)	24.27M	29.46M	28.94M	68.74M	50.49M
(Gain) Loss From Sale Of Asset	-1M	259K	662K	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	3.02M	-30K
Other Operating Activities, Total	14.16M	-66.23M	11.62M	-82.3M	-21.03M
Change In Accounts Receivable	-62.1M	-74.37M	-21.18M	21.62M	-106M
Change In Inventories	18K	-74.63M	-153M	24.38M	26.6M
Change In Accounts Payable	52.69M	33.73M	47.1M	-63.3M	15.27M
Change in Other Net Operating Assets	61.04M	5.76M	805K	32.41M	27.94M
Cash from Operations	363M	188M	251M	247M	210M
Capital Expenditure	-30.12M	-42.8M	-65.65M	-86.81M	-39.39M
Sale of Property, Plant, and Equipment	4.83M	218K	355K	66K	13.69M
Cash Acquisitions	-11.51M	-	-10.66M	-1.01B	-2.47M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-35.98M	-39.17M	-48.21M	-65.39M	-37.2M
Investment in Marketable and Equity Securities, Total	-2.42M	-67.14M	2.42M	-3.9M	-12.37M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-	-	10.77M	750M	-13.28M
Cash from Investing	-75.2M	-149M	-111M	-412M	-91.03M
Short Term Debt Issued, Total	420K	-	-	206K	68K
Long-Term Debt Issued, Total	3.98M	-	-	400M	-
Total Debt Issued	4.4M	-	-	400M	68K
Short Term Debt Repaid, Total	-	-597K	-8K	-	-
Long-Term Debt Repaid, Total	-17.73M	-21.36M	-22.99M	-23.3M	-23.36M
Total Debt Repaid	-17.73M	-21.96M	-23M	-23.3M	-23.36M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-150M	-
Common Dividends Paid	-44.72M	-80.5M	-98.38M	-98.2M	-52.52M
Common & Preferred Stock Dividends Paid	-44.72M	-80.5M	-98.38M	-98.2M	-52.52M
Other Financing Activities, Total	-228M	64.22M	-13.71M	47.62M	-33.01M
Cash from Financing	-286M	-38.24M	-135M	176M	-109M
Foreign Exchange Rate Adjustments	-337K	-779K	-1.92M	-1.58M	-3.02M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	1.24M	290K	2.87M	9.68M	6.98M
Supplemental Items
Cash Interest Paid	1.63M	1.52M	3.95M	12.28M	21.51M
Cash Income Tax Paid (Refund)	97.91M	120M	107M	117M	76.93M
Levered Free Cash Flow	59.29M	133M	76.81M	790M	87.32M
Unlevered Free Cash Flow	64.65M	139M	86.34M	809M	104M
Change In Net Working Capital	162M	98.59M	94.9M	-711M	85.4M
Net Debt Issued / Repaid	-13.33M	-21.96M	-23M	377M	-23.3M

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.5	9.55	7.55	3.65	4.11
Return on Total Capital	13.95	12.6	9.85	4.74	5.29
Return On Equity %	15.19	15.96	13.9	8.52	6.8
Return on Common Equity	15.29	16	13.91	8.51	6.79
Margin Analysis
Gross Profit Margin %	58.73	59.26	57.71	52.69	52.76
SG&A Margin	22.15	22.98	24.07	27.01	28.13
EBITDA Margin %	23.62	22.05	17.96	10.89	12.29
EBITA Margin %	22.58	21.01	16.99	9.66	11.08
EBIT Margin %	22.49	20.96	16.93	9.07	10.02
Income From Continuing Operations Margin %	14.42	15.55	13.98	8.72	6.39
Net Income Margin %	14.35	15.45	13.9	8.65	6.34
Net Avail. For Common Margin %	14.35	15.45	13.9	8.65	6.34
Normalized Net Income Margin	12.77	11.47	11.95	5.65	5.26
Levered Free Cash Flow Margin	3.6	6.98	3.68	38.24	3.92
Unlevered Free Cash Flow Margin	3.93	7.28	4.13	39.13	4.67
Asset Turnover
Asset Turnover	0.75	0.73	0.71	0.64	0.66
Fixed Assets Turnover	11.08	10.05	9.25	8.03	8.1
Receivables Turnover (Average Receivables)	5.64	5.15	5	4.81	4.65
Inventory Turnover (Average Inventory)	2.37	2.32	1.96	1.85	2.04
Short Term Liquidity
Current Ratio	3.58	3.32	3.4	2.13	2.35
Quick Ratio	2.9	2.55	2.33	1.06	1.32
Operating Cash Flow to Current Liabilities	0.81	0.35	0.45	0.43	0.39
Days Sales Outstanding (Average Receivables)	64.7	70.94	73	76.13	78.56
Days Outstanding Inventory (Average Inventory)	153.81	157.52	186.52	197.84	179.26
Average Days Payable Outstanding	63.68	70.07	76.68	77.95	68.03
Cash Conversion Cycle (Average Days)	154.83	158.39	182.84	196.03	189.79
Long Term Solvency
Total Debt/Equity	7.23	6.3	7.17	26.93	25.14
Total Debt / Total Capital	6.74	5.93	6.69	21.22	20.09
LT Debt/Equity	6.08	5.24	6.16	25.61	23.89
Long-Term Debt / Total Capital	5.67	4.93	5.75	20.18	19.09
Total Liabilities / Total Assets	29.99	28.08	28.36	39.39	37.48
EBIT / Interest Expense	43.18	43.84	23.19	6.37	8.39
EBITDA / Interest Expense	47.53	48.27	26.15	8.55	11.25
(EBITDA - Capex) / Interest Expense	44.02	43.56	21.84	5.6	9.77
Total Debt / EBITDA	0.3	0.29	0.39	2.2	1.79
Net Debt / EBITDA	0.28	0.27	0.36	2.12	1.7
Total Debt / (EBITDA - Capex)	0.32	0.32	0.47	3.36	2.06
Net Debt / (EBITDA - Capex)	0.3	0.3	0.44	3.24	1.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.31	15.55	9.8	-1.11	7.82
Gross Profit, 1 Yr. Growth %	29.74	16.58	6.93	-9.71	7.95
EBITDA, 1 Yr. Growth %	94.43	7.85	-10.27	-39.29	27.41
EBITA, 1 Yr. Growth %	104.94	7.51	-10.95	-43.04	30.33
EBIT, 1 Yr. Growth %	109.34	7.69	-11.07	-46.31	26.01
Earnings From Cont. Operations, 1 Yr. Growth %	92.45	24.58	-1.32	-38.31	-20.99
Net Income, 1 Yr. Growth %	93.06	24.39	-1.2	-38.45	-20.99
Normalized Net Income, 1 Yr. Growth %	118.52	3.8	14.83	-52.67	6.08
Diluted EPS Before Extra, 1 Yr. Growth %	93.06	24.39	-1.2	-38.05	-19.8
Accounts Receivable, 1 Yr. Growth %	24.26	28.63	1.73	3.95	18.88
Inventory, 1 Yr. Growth %	0.01	33.65	35.92	3.14	-7.33
Net Property, Plant and Equip., 1 Yr. Growth %	48.12	13.48	24.52	5.28	8.32
Total Assets, 1 Yr. Growth %	18.92	17.82	7.44	11.88	0.3
Tangible Book Value, 1 Yr. Growth %	21.32	19.47	10.22	-56.38	14.86
Common Equity, 1 Yr. Growth %	15.9	21.44	7.16	-5.45	3.66
Cash From Operations, 1 Yr. Growth %	103.14	-48.11	33.3	-1.41	-15.15
Capital Expenditures, 1 Yr. Growth %	2.72	42.1	53.38	32.24	-54.62
Levered Free Cash Flow, 1 Yr. Growth %	-1.6	124.03	-41.84	968.78	-88.86
Unlevered Free Cash Flow, 1 Yr. Growth %	-16.36	114.25	-37.32	868.76	-87.04
Dividend Per Share, 1 Yr. Growth %	80	22.22	0	-45.45	-8.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.23	19.37	12.64	4.2	3.26
Gross Profit, 2 Yr. CAGR %	7.83	22.98	11.65	-1.74	-1.28
EBITDA, 2 Yr. CAGR %	17.02	44.81	-1.77	-26.65	-14.07
EBITA, 2 Yr. CAGR %	17.55	48.43	-2.3	-29.24	-16.07
EBIT, 2 Yr. CAGR %	18.42	50.15	-2.28	-31.35	-20.02
Earnings From Cont. Operations, 2 Yr. CAGR %	21.62	54.84	10.88	-21.97	-30.18
Net Income, 2 Yr. CAGR %	21.61	54.97	10.86	-22.02	-30.27
Normalized Net Income, 2 Yr. CAGR %	21.32	50.61	8.97	-26.7	-31.1
Diluted EPS Before Extra, 2 Yr. CAGR %	21.61	54.97	10.86	-21.76	-29.51
Accounts Receivable, 2 Yr. CAGR %	0.02	26.43	14.14	2.84	11.17
Inventory, 2 Yr. CAGR %	3.31	15.61	34.78	18.4	-2.24
Net Property, Plant and Equip., 2 Yr. CAGR %	26.34	29.65	18.87	14.5	6.79
Total Assets, 2 Yr. CAGR %	8.85	18.36	12.51	9.64	5.93
Tangible Book Value, 2 Yr. CAGR %	12.82	20.39	14.75	-30.66	-29.22
Common Equity, 2 Yr. CAGR %	8.93	18.64	14.08	0.66	-1
Cash From Operations, 2 Yr. CAGR %	28.5	2.67	-16.83	14.64	-8.54
Capital Expenditures, 2 Yr. CAGR %	21.67	20.82	47.63	42.41	-22.54
Levered Free Cash Flow, 2 Yr. CAGR %	-41.25	48.47	13.83	144.6	8.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-39.49	33.86	15.57	142.27	11.59
Dividend Per Share, 2 Yr. CAGR %	17.67	48.32	10.55	-26.15	-29.29
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.74	9.25	16.09	7.85	5.39
Gross Profit, 3 Yr. CAGR %	10.83	10.67	17.38	4.02	1.39
EBITDA, 3 Yr. CAGR %	21.35	13.88	23.34	-16.67	-13.18
EBITA, 3 Yr. CAGR %	23	14.1	25.06	-18.74	-14.77
EBIT, 3 Yr. CAGR %	23.52	14.73	25.97	-20.31	-17.5
Earnings From Cont. Operations, 3 Yr. CAGR %	23.46	22.6	33.25	-8.8	-21.65
Net Income, 3 Yr. CAGR %	23.16	22.53	33.38	-8.89	-21.68
Normalized Net Income, 3 Yr. CAGR %	23.86	15.17	37.41	-17.79	-18.63
Diluted EPS Before Extra, 3 Yr. CAGR %	23.16	22.53	33.38	-8.68	-21.11
Accounts Receivable, 3 Yr. CAGR %	3.61	8.77	17.42	10.64	7.93
Inventory, 3 Yr. CAGR %	4.9	12.57	22.02	23.28	9.11
Net Property, Plant and Equip., 3 Yr. CAGR %	45.71	21.9	27.92	14.16	12.4
Total Assets, 3 Yr. CAGR %	12.97	11.76	14.61	12.3	6.43
Tangible Book Value, 3 Yr. CAGR %	6.85	14.99	16.9	-16.88	-17.96
Common Equity, 3 Yr. CAGR %	8.66	12.95	14.68	7.16	1.65
Cash From Operations, 3 Yr. CAGR %	24.66	-5.02	12.01	-11.98	3.7
Capital Expenditures, 3 Yr. CAGR %	22.13	28.13	30.82	42.31	-2.73
Levered Free Cash Flow, 3 Yr. CAGR %	16.16	-8.21	8.43	137.1	-12.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.24	-7.77	3.76	132.13	-8.96
Dividend Per Share, 3 Yr. CAGR %	17.84	19.17	30.06	-12.64	-20.63
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.64	9.84	10.28	7.2	10.78
Gross Profit, 5 Yr. CAGR %	10.79	11.42	11.16	5.53	9.53
EBITDA, 5 Yr. CAGR %	18.17	17.1	11.51	-4.55	6.47
EBITA, 5 Yr. CAGR %	18.92	17.87	12.18	-5.8	6.34
EBIT, 5 Yr. CAGR %	19.36	18.28	12.47	-6.63	4.76
Earnings From Cont. Operations, 5 Yr. CAGR %	18.9	16.86	18.26	2.33	2.89
Net Income, 5 Yr. CAGR %	19.16	16.93	18.09	2.27	2.9
Normalized Net Income, 5 Yr. CAGR %	19.27	14.3	17.67	-3.95	4.01
Diluted EPS Before Extra, 5 Yr. CAGR %	16.91	15.91	18.09	2.4	3.35
Accounts Receivable, 5 Yr. CAGR %	5.11	7.68	7.7	6.26	14.88
Inventory, 5 Yr. CAGR %	6.57	10.31	15.96	14.87	11.67
Net Property, Plant and Equip., 5 Yr. CAGR %	22.89	28.96	34.31	18.88	19
Total Assets, 5 Yr. CAGR %	13.94	11.7	12.78	10.91	11.05
Tangible Book Value, 5 Yr. CAGR %	16.73	9.22	9.95	-6.07	-4.36
Common Equity, 5 Yr. CAGR %	15.77	10.64	10.79	7.86	8.13
Cash From Operations, 5 Yr. CAGR %	26.54	37.91	6.03	2.4	3.29
Capital Expenditures, 5 Yr. CAGR %	18.68	25.67	31.76	33.66	6.08
Levered Free Cash Flow, 5 Yr. CAGR %	-2.67	-10.19	15.22	35.7	7.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.58	-9.35	17.16	35.57	6.1
Dividend Per Share, 5 Yr. CAGR %	16.47	14.87	14.87	-1.59	1.92